Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Atul Pathak

Showing results (111-120 of 200) with videos related to

Pageof 20
Sort By:
Circulation. Cardiovascular Quality and Outcomes|December 9, 2022
Patient Preferences for Pharmaceutical and Device-Based Treatments for Uncontrolled Hypertension: Discrete Choice ExperimentDavid E Kandzari, Michael A Weber, Christine Poulos, et al.
International Journal of Cardiology|February 19, 2013
Cardiorenal anemia syndrome in chronic heart failure contributes to increased sympathetic nerve activityNicolas Franchitto, Fabien Despas, Marc Labrunee, et al.
Journal of Hypertension|June 23, 2009
Excessive sympathetic activation in heart failure with chronic renal failure: role of chemoreflex activationFabien Despas, Nicolas Detis, Nicolas Dumonteil, et al.
Fundamental & Clinical Pharmacology|June 21, 2013
Bortezomib and heart failure: case-report and review of the French Pharmacovigilance databaseBenjamin Honton, Fabien Despas, Nicolas Dumonteil, et al.
American Journal of Physiology. Heart and Circulatory Physiology|October 30, 2007
Effects of enoximone on peripheral and central chemoreflex responses in humansMarko Gujic, Céline Dreyfuss, Jean-François Argacha, et al.
American Journal of Cardiovascular Disease|July 12, 2017
Direct evidence of sympathetic hyperactivity in patients with vasospastic anginaNicolas Boudou, Fabien Despas, Jérôme Van Rothem, et al.
American Journal of Physical Medicine & Rehabilitation|August 30, 2014
Whole-body strength training using a Huber Motion Lab in coronary heart disease patients: safety, tolerance, fuel selection, and energy expenditure aspects and optimizationThibaut Guiraud, Marc Labrunée, Fabien Pillard, et al.
The Annals of Pharmacotherapy|June 28, 2002
Celecoxib-associated torsade de pointesAtul Pathak, Serge Boveda, Pascal Defaye, et al.
Journal of Cardiovascular Electrophysiology|December 18, 2007
Sympathoexcitation increases the QT/RR slope in healthy men: differential effects of hypoxia, dobutamine, and phenylephrineOlivier Xhaët, Jean-Francois Argacha, Atul Pathak, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|July 5, 2018
Will SPYRAL HTN-ON MED change my practice? SPYRAL HTN-ON MED: a prospective, randomised, sham-controlled trial on renal denervation in the presence of antihypertensive medicationsSebastian Ewen, Lucas Lauder, Michel Azizi, et al.
Pageof 20

Showing results (111-120 of 200) with videos related to

Sort By:
Pageof 20
Circulation. Cardiovascular Quality and Outcomes|December 9, 2022
Patient Preferences for Pharmaceutical and Device-Based Treatments for Uncontrolled Hypertension: Discrete Choice ExperimentDavid E Kandzari, Michael A Weber, Christine Poulos, et al.
International Journal of Cardiology|February 19, 2013
Cardiorenal anemia syndrome in chronic heart failure contributes to increased sympathetic nerve activityNicolas Franchitto, Fabien Despas, Marc Labrunee, et al.
Journal of Hypertension|June 23, 2009
Excessive sympathetic activation in heart failure with chronic renal failure: role of chemoreflex activationFabien Despas, Nicolas Detis, Nicolas Dumonteil, et al.
Fundamental & Clinical Pharmacology|June 21, 2013
Bortezomib and heart failure: case-report and review of the French Pharmacovigilance databaseBenjamin Honton, Fabien Despas, Nicolas Dumonteil, et al.
American Journal of Physiology. Heart and Circulatory Physiology|October 30, 2007
Effects of enoximone on peripheral and central chemoreflex responses in humansMarko Gujic, Céline Dreyfuss, Jean-François Argacha, et al.
American Journal of Cardiovascular Disease|July 12, 2017
Direct evidence of sympathetic hyperactivity in patients with vasospastic anginaNicolas Boudou, Fabien Despas, Jérôme Van Rothem, et al.
American Journal of Physical Medicine & Rehabilitation|August 30, 2014
Whole-body strength training using a Huber Motion Lab in coronary heart disease patients: safety, tolerance, fuel selection, and energy expenditure aspects and optimizationThibaut Guiraud, Marc Labrunée, Fabien Pillard, et al.
The Annals of Pharmacotherapy|June 28, 2002
Celecoxib-associated torsade de pointesAtul Pathak, Serge Boveda, Pascal Defaye, et al.
Journal of Cardiovascular Electrophysiology|December 18, 2007
Sympathoexcitation increases the QT/RR slope in healthy men: differential effects of hypoxia, dobutamine, and phenylephrineOlivier Xhaët, Jean-Francois Argacha, Atul Pathak, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|July 5, 2018
Will SPYRAL HTN-ON MED change my practice? SPYRAL HTN-ON MED: a prospective, randomised, sham-controlled trial on renal denervation in the presence of antihypertensive medicationsSebastian Ewen, Lucas Lauder, Michel Azizi, et al.
Pageof 20